InvestSMART

Xenitra Limited (ASX: XEN) - Announcements

Current share price for XEN : $0.002 0.001 (33.33%)+

ASX company news and announcements for Xenitra Limited (XEN) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Xenitra Limited (XEN) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Xenitra Limited (XEN), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Xenitra Limited (XEN)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$9 Xenitra Investor Webinar 10 Jun 2026 9:31AM $0.003 $0.002 fallen by 20%
$9 $1.1m in OPAL-Tokenised Product Sales in First 7 Weeks 4 Jun 2026 9:08AM $0.003 $0.002 fallen by 33.33%
$9 XEN Appointed as Exclusive Biomiq Skincare China Distributor 2 Jun 2026 8:23AM $0.003 $0.002 fallen by 20%
$9 Notice Under Section 708A 19 May 2026 4:34PM $0.003 $0.002 fallen by 33.33%
$9 Application for quotation of securities - XEN 19 May 2026 4:31PM $0.003 $0.002 fallen by 33.33%
$9 Product sales of $500k in first month of OPAL token launch 14 May 2026 9:19AM $0.003 $0.002 fallen by 33.33%
$9 Investor Presentation 7 May 2026 10:08AM $0.003 $0.002 fallen by 33.33%
$9 Proposed issue of securities - XEN 7 May 2026 9:21AM $0.004 $0.002 fallen by 50%
$9 $1.25m Raised to Support Next Phase of Growth 7 May 2026 9:21AM $0.004 $0.002 fallen by 50%
$9 Trading Halt 5 May 2026 10:49AM $0.004 $0.002 fallen by 50%
$9 Pause in Trading 5 May 2026 9:54AM $0.004 $0.002 fallen by 50%
$9 Change of Address 30 Apr 2026 5:10PM $0.004 $0.002 fallen by 42.86%
$9 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2026 4:23PM $0.004 $0.002 fallen by 42.86%
$9 OPAL token launch of EZZ products sells $100k in first week 21 Apr 2026 8:16AM $0.004 $0.002 fallen by 42.86%
$9 Q3 Sales rise by over 305% to $8.3m 16 Apr 2026 9:12AM $0.003 $0.002 fallen by 33.33%
$9 Acquisition of Fukang OTC Pharmacy 15 Apr 2026 9:20AM $0.003 $0.002 fallen by 33.33%
$9 Change of Director's Interest Notice - ZG 9 Apr 2026 5:10PM $0.003 $0.002 fallen by 33.33%
$9 Change of Director's Interest Notice - LL 9 Apr 2026 5:10PM $0.003 $0.002 fallen by 33.33%
$9 Change of Director's Interest Notice - CH 9 Apr 2026 5:09PM $0.003 $0.002 fallen by 33.33%
$9 Change of Director's Interest Notice - AN 9 Apr 2026 5:08PM $0.003 $0.002 fallen by 33.33%
$9 Notice Under Section 708A 8 Apr 2026 5:02PM $0.003 $0.002 fallen by 33.33%
$9 Application for quotation of securities - XEN 8 Apr 2026 4:53PM $0.003 $0.002 fallen by 33.33%
$9 Notification regarding unquoted securities - XEN 7 Apr 2026 9:44AM $0.003 $0.002 fallen by 33.33%
$9 Notification regarding unquoted securities - XEN 7 Apr 2026 9:44AM $0.003 $0.002 fallen by 33.33%
$9 Notification regarding unquoted securities - XEN 7 Apr 2026 9:44AM $0.003 $0.002 fallen by 33.33%

1 - 25 of 80 results

Page 1 of 4

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.